chr11-55651032-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001004059.3(OR4S2):āc.129C>Gā(p.Ile43Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000182 in 1,469,408 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004059.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4S2 | NM_001004059.3 | c.129C>G | p.Ile43Met | missense_variant | 2/2 | ENST00000641692.1 | NP_001004059.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4S2 | ENST00000641692.1 | c.129C>G | p.Ile43Met | missense_variant | 2/2 | NM_001004059.3 | ENSP00000493389.1 |
Frequencies
GnomAD3 genomes AF: 0.000261 AC: 36AN: 138124Hom.: 3 Cov.: 25
GnomAD3 exomes AF: 0.000184 AC: 42AN: 228460Hom.: 8 AF XY: 0.000162 AC XY: 20AN XY: 123720
GnomAD4 exome AF: 0.000174 AC: 231AN: 1331196Hom.: 50 Cov.: 28 AF XY: 0.000142 AC XY: 94AN XY: 663460
GnomAD4 genome AF: 0.000260 AC: 36AN: 138212Hom.: 3 Cov.: 25 AF XY: 0.000328 AC XY: 22AN XY: 67056
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 21, 2023 | The c.129C>G (p.I43M) alteration is located in exon 1 (coding exon 1) of the OR4S2 gene. This alteration results from a C to G substitution at nucleotide position 129, causing the isoleucine (I) at amino acid position 43 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at